Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,223 | 33,490 | 36,874 | 20,489 | 23,560 |
| Other current assets | 135 | 178 | 224 | 60 | 111 |
| TOTAL | $32,358 | $33,667 | $37,097 | $20,549 | $23,671 |
| Non-Current Assets | |||||
| PPE Net | 8 | 9 | 6 | 7 | 8 |
| TOTAL | $8 | $9 | $6 | $7 | $8 |
| Total Assets | $32,365 | $33,677 | $37,103 | $20,556 | $23,679 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,280 | 2,132 | 1,527 | 1,847 | 1,843 |
| Accrued Expenses | 37 | 454 | 449 | 898 | 838 |
| TOTAL | $2,318 | $2,585 | $1,977 | $2,746 | $2,681 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,318 | $2,585 | $1,977 | $2,746 | $2,681 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 348 | 327 | 327 | 327 | 215 |
| Common Shares | 389 | 388 | 20 | 13 | 13 |
| Retained earnings | -105,676 | -100,795 | -96,043 | -92,320 | -88,528 |
| TOTAL | $30,048 | $31,091 | $35,126 | $17,810 | $20,998 |
| Total Liabilities And Equity | $32,365 | $33,677 | $37,103 | $20,556 | $23,679 |